Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Serpiginous choroiditis - clinical study].

G Munteanu1, M Munteanu, I Zolog

  • 1Clinica de Oftalmologie Timişoara.

Oftalmologia (Bucharest, Romania : 1990)
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sub-inner limiting membrane hemorrhage in a patient with Terson syndrome.

International ophthalmology·2018
Same author

HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.

Journal of viral hepatitis·2017
Same author

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.

Alimentary pharmacology & therapeutics·2016
Same author

Shear wave elastography: An accurate technique to stage liver fibrosis in chronic liver diseases.

Diagnostic and interventional imaging·2015
Same author

Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses.

Blood cancer journal·2015
Same author

Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B.

Alimentary pharmacology & therapeutics·2015
Same journal

[Macular serpiginous choroiditis complicated by macular hole].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Therapeutic approach in persistent diabetic macular edema].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Preliminary results of treatment with aflibercept].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

MANAGEMENT OF DIABETIC RETINOPATHY, PREVALENCE AND CLINICAL CLASSIFICATION.

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Changes in intraocular pressure depending on posture].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Treatment for penetrating wound caused by metallic intraocular foreign body].

Oftalmologia (Bucharest, Romania : 1990)·2015
See all related articles

This 12-year study of 34 serpiginous choroiditis cases found bilateral involvement and significant vision loss, especially with macular disease. A triple immunosuppressant therapy (azathioprine, cyclosporine, prednisone) yielded positive outcomes.

Area of Science:

  • Ophthalmology
  • Immunology

Context:

  • Serpiginous choroiditis is a rare, bilateral inflammatory eye condition.
  • This study analyzes 34 cases over a 12-year period.

Purpose:

  • To describe the clinical characteristics, evolution, and treatment outcomes of serpiginous choroiditis.
  • To evaluate the efficacy of a triple immunosuppressant regimen.

Summary:

  • Retrospective analysis of 34 serpiginous choroiditis patients (average age 36).
  • Juxtapapillary (99.1%) and macular (5.9%) onset noted, with bilateralism in all cases and severe visual acuity reduction in macular cases.
  • Characteristic ophthalmoscopic and angiofluorographic findings with pseudopodia-like lesion extension.
  • Discusses differential diagnosis and pathogenesis (hereditary, inflammatory, vascular).

Related Experiment Videos

Impact:

  • Highlights the specific clinical course and diagnostic features of serpiginous choroiditis.
  • Demonstrates the effectiveness of combined immunosuppressive therapy (azathioprine, cyclosporine, prednisone) in managing this condition.